WuXi AppTec Co., Ltd. (BKK:WUXIAT80)

Thailand flag Thailand · Delayed Price · Currency is THB
4.400
-0.200 (-4.35%)
Last updated: Mar 4, 2026, 2:48 PM ICT
Market Cap1.26T +70.3%
Revenue (ttm)200.16B +23.2%
Net Income68.39B +85.9%
EPS21.23 +53.2%
Shares Outn/a
PE Ratio18.37
Forward PE17.24
Dividendn/a
Ex-Dividend Daten/a
Volume89,559
Average Volume223,367
Open4.420
Previous Close4.600
Day's Range4.360 - 4.420
52-Week Range3.960 - 5.200
Betan/a
RSI43.72
Earnings DateMar 24, 2026

About WuXi AppTec

WuXi AppTec Co., Ltd., an investment holding company, provides research and manufacturing services to discover, develop, and manufacture spectrum for small molecule drugs in the People’s Republic of China, the United States, Europe, and internationally. The company operates through WuXi Chemistry, WuXi Testing, WuXi Biology, and Others segments. It offers contract research, development, and manufacturing organization (CDRMO) services for new drug development from discovery to commercial covering various categories for various synthetic molecula... [Read more]

Industry Commercial Physical and Biological Research
Founded 2000
Employees 39,414
Stock Exchange Stock Exchange of Thailand
Ticker Symbol WUXIAT80
Full Company Profile

Financial Performance

In 2024, WuXi AppTec's revenue was 37.92 billion, a decrease of -1.97% compared to the previous year's 38.68 billion. Earnings were 9.45 billion, a decrease of -1.63%.

Financial numbers in CNY Financial Statements